These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35583652)

  • 21. Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries.
    Amenta V; Aschberger K; Arena M; Bouwmeester H; Botelho Moniz F; Brandhoff P; Gottardo S; Marvin HJ; Mech A; Quiros Pesudo L; Rauscher H; Schoonjans R; Vettori MV; Weigel S; Peters RJ
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):463-76. PubMed ID: 26169479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New sector of employment--a review of data on nanoproduction, research and development in the field of nanotechnology in Poland].
    Popławska M; Mikołajczyk U; Bujak-Pietrek S
    Med Pr; 2015; 66(4):575-82. PubMed ID: 26536974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nanotechnology and food safety].
    De Ariño Otxoa A
    Nutr Hosp; 2018 Jun; 35(Spec No4):146-149. PubMed ID: 30070138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State of the art on the initiatives and activities relevant to risk assessment and risk management of nanotechnologies in the food and agriculture sectors.
    Takeuchi MT; Kojima M; Luetzow M
    Food Res Int; 2014 Oct; 64():976-981. PubMed ID: 30011741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frameworks and tools for risk assessment of manufactured nanomaterials.
    Hristozov D; Gottardo S; Semenzin E; Oomen A; Bos P; Peijnenburg W; van Tongeren M; Nowack B; Hunt N; Brunelli A; Scott-Fordsmand JJ; Tran L; Marcomini A
    Environ Int; 2016 Oct; 95():36-53. PubMed ID: 27523267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the measures for environmental and health safety in the development and implementation of nanotechnologies and nanomaterials].
    Onishchenko GG
    Vestn Ross Akad Med Nauk; 2011; (3):28-31. PubMed ID: 21542372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Health risks of engineered nanomaterials and nanotechnologies].
    Savolainen K; Vainio H
    Duodecim; 2011; 127(11):1097-104. PubMed ID: 21755801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Life Cycle of Engineered Nanoparticles.
    González-Gálvez D; Janer G; Vilar G; Vílchez A; Vázquez-Campos S
    Adv Exp Med Biol; 2017; 947():41-69. PubMed ID: 28168665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary on "Safe(r) by design implementation in the nanotechnology industry" [NanoImpact 20 (2020) 100267] and "Integrative approach in a safe by design context combining risk, life cycle and socio-economic assessment for safer and sustainable nanomaterials" [NanoImpact 23 (2021) 100335].
    Jantunen P; Rauscher H; Riego Sintes J; Rasmussen K
    NanoImpact; 2021 Oct; 24():100356. PubMed ID: 35559815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health and safety practices in the nanomaterials workplace: results from an international survey.
    Conti JA; Killpack K; Gerritzen G; Huang L; Mircheva M; Delmas M; Harthorn BH; Appelbaum RP; Holden PA
    Environ Sci Technol; 2008 May; 42(9):3155-62. PubMed ID: 18522088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Essential Elements of a Risk Governance Framework for Current and Future Nanotechnologies.
    Stone V; Führ M; Feindt PH; Bouwmeester H; Linkov I; Sabella S; Murphy F; Bizer K; Tran L; Ågerstrand M; Fito C; Andersen T; Anderson D; Bergamaschi E; Cherrie JW; Cowan S; Dalemcourt JF; Faure M; Gabbert S; Gajewicz A; Fernandes TF; Hristozov D; Johnston HJ; Lansdown TC; Linder S; Marvin HJP; Mullins M; Purnhagen K; Puzyn T; Sanchez Jimenez A; Scott-Fordsmand JJ; Streftaris G; van Tongeren M; Voelcker NH; Voyiatzis G; Yannopoulos SN; Poortvliet PM
    Risk Anal; 2018 Jul; 38(7):1321-1331. PubMed ID: 29240986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risks to health care workers from nano-enabled medical products.
    Murashov V; Howard J
    J Occup Environ Hyg; 2015; 12(6):D75-85. PubMed ID: 25950806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory developments and their impacts to the nano-industry: A case study for nano-additives in 3D printing.
    Taylor AA; Freeman EL; van der Ploeg MJC
    Ecotoxicol Environ Saf; 2021 Jan; 207():111458. PubMed ID: 33254383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk management strategy to increase the safety of workers in the nanomaterials industry.
    Ling MP; Lin WC; Liu CC; Huang YS; Chueh MJ; Shih TS
    J Hazard Mater; 2012 Aug; 229-230():83-93. PubMed ID: 22727485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General principles of medical surveillance: implications for workers potentially exposed to nanomaterials.
    Trout DB
    J Occup Environ Med; 2011 Jun; 53(6 Suppl):S22-4. PubMed ID: 21606848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Occupational Risk Prevention of Nanomaterials Manufactured in Construction Sites in the EU.
    López-Alonso M; Díaz-Soler B; Martínez-Rojas M; Fito-López C; Martínez-Aires MD
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Training for Workers and Safety Representatives on Manufactured Nanomaterials.
    Castillo APD
    New Solut; 2019 May; 29(1):36-52. PubMed ID: 30782079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing adoption of precautionary risk management guidance for nanomaterials, an emerging occupational hazard.
    Schubauer-Berigan MK; Dahm MM; Schulte PA; Hodson L; Geraci CL
    J Occup Environ Hyg; 2015; 12(1):69-75. PubMed ID: 25093252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRAAC framework to improve regulatory acceptance and wider usability of tools and methods for safe innovation and sustainability of manufactured nanomaterials.
    Shandilya N; Barreau MS; Suarez-Merino B; Porcari A; Pimponi D; Jensen KA; Fransman W; Franken R
    NanoImpact; 2023 Apr; 30():100461. PubMed ID: 37040858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.
    Stone V; Johnston HJ; Balharry D; Gernand JM; Gulumian M
    Risk Anal; 2016 Aug; 36(8):1538-50. PubMed ID: 27285586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.